Renal Replacement Therapy — MCQs
The following are complications of haemodialysis except
A CKD patient develops serum K+ 7.2 mEq/L without ECG changes. Best initial management?
IV fluid replacement (volume & rate) in a trauma patient is determined by:
For shock patient, best guideline to check for adequacy of fluid replacement therapy:
In case of PSGN complication commonly seen are all except :
What is the best treatment for anemia in patients with Chronic Renal Failure (CRF)?
Assertion: In a patient with chronic kidney disease (CKD) and metabolic acidosis, sodium bicarbonate should be initiated to correct acidosis. Reason: Sodium bicarbonate therapy reduces the progression of kidney disease by decreasing tubular injury and slowing fibrosis.
The best measure of organ perfusion and the best monitor of adequacy of shock therapy is
Which among the following is an absolute contraindication of Hormone replacement therapy?
In a post-burn patient, which of the following is true?
Renal Replacement Therapy Indian Medical PG Practice Questions and MCQs
Question 1: The following are complications of haemodialysis except
- A. Chest pain
- B. Bleeding tendency
- C. Hypotension
- D. Hypercalcemia (Correct Answer)
Explanation: ***Hypercalcemia*** - **Hypercalcemia** is generally *not* a complication of hemodialysis; instead, patients often experience **hypocalcemia** due to chelation of calcium by dialysate or secondary hyperparathyroidism. - While dialysate can be adjusted to increase calcium, persistent hypercalcemia is more indicative of other underlying issues, such as **over-supplementation** or **adynamic bone disease**, rather than a direct complication of the dialysis procedure itself. *Hypotension* - **Hypotension** is a common complication of hemodialysis, often caused by **excessive fluid removal**, rapid solute shifts, or vasodilation [1]. - It can lead to symptoms like dizziness, nausea, and cramping, and in severe cases, may cause organ hypoperfusion. *Chest pain* - **Chest pain** can occur during hemodialysis due to several factors, including **myocardial ischemia** from hypotension or fluid shifts, or musculoskeletal pain [1]. - It may also be related to **pericarditis** or **pleuritis**, which are uremic complications sometimes exacerbated or triggered by dialysis. *Bleeding tendency* - A **bleeding tendency** is a well-known complication of hemodialysis, primarily due to the use of **anticoagulants** like heparin during the procedure to prevent clotting in the dialyzer [1]. - Additionally, chronic **uremia** itself can cause platelet dysfunction, further contributing to an increased risk of bleeding.
Question 2: A CKD patient develops serum K+ 7.2 mEq/L without ECG changes. Best initial management?
- A. Emergency dialysis
- B. Sodium polystyrene
- C. Insulin with glucose
- D. Calcium gluconate (Correct Answer)
Explanation: **Calcium gluconate** - **Calcium gluconate** is the best initial management for severe hyperkalemia, particularly when the potassium level is very high (above 6.5 mEq/L) even without ECG changes [1]. It acts quickly to directly stabilize the cardiac membrane by **antagonizing the effects of potassium on myocardial excitability**, thereby preventing life-threatening arrhythmias [1]. - It provides immediate cardioprotection, buying time for other therapies to shift potassium into cells or remove it from the body. *Emergency dialysis* - While **dialysis** is the most effective way to remove potassium from the body, it is typically reserved for cases of severe, refractory hyperkalemia, or when other therapies have failed [3]. - It is not the *initial* management for immediate cardiac stabilization, especially if no ECG changes are present and calcium can be administered more rapidly. *Sodium polystyrene* - **Sodium polystyrene sulfonate (Kayexalate)** is a potassium-binding resin that works in the gastrointestinal tract to exchange sodium for potassium, thus removing potassium from the body. - Its onset of action is slow (hours to days), making it inappropriate for acute, severe hyperkalemia requiring immediate intervention. *Insulin with glucose* - **Insulin with glucose** therapy promotes the intracellular shift of potassium, temporarily lowering serum potassium levels [2]. - While effective, its onset of action is typically 15-30 minutes, and it functions as a temporary measure to redistribute potassium, not to acutely stabilize the cardiac membrane, which is the primary concern when potassium is severely elevated.
Question 3: IV fluid replacement (volume & rate) in a trauma patient is determined by:
- A. Chest condition
- B. BP
- C. CVP
- D. Urine output (Correct Answer)
Explanation: ***Urine output*** - **Urine output** is a sensitive indicator of **renal perfusion** and overall **hemodynamic stability**, reflecting adequate tissue perfusion and fluid resuscitation in trauma patients. - Maintaining a urine output of **0.5-1.0 mL/kg/hour** is a common target during fluid resuscitation, demonstrating effective restoration of circulating volume. *Chest condition* - The **"chest condition"** (interpreted as respiratory status or thoracic trauma) primarily guides management of ventilatory support and thoracic interventions, not directly IV fluid rates. - While significant chest trauma can impact hemodynamics, it does not alone determine the specific **volume and rate** of IV fluid resuscitation. *BP* - **Blood pressure (BP)** can be a delayed and insensitive indicator of **hypovolemia** in trauma, as compensatory mechanisms can maintain BP until significant blood loss has occurred. - Relying solely on BP may lead to inadequate resuscitation or fluid overload, especially in patients with pre-existing hypertension. *CVP* - **Central Venous Pressure (CVP)** reflects **right atrial pressure** and can be influenced by multiple factors, including cardiac function, intrathoracic pressure, and venous tone, making it an unreliable sole indicator of fluid status in trauma. - CVP measurements can be misleading in situations like **cardiac tamponade** or **tension pneumothorax**, which are common in severe trauma.
Question 4: For shock patient, best guideline to check for adequacy of fluid replacement therapy:
- A. Central Venous Pressure
- B. Urine output (Correct Answer)
- C. Hemoglobin
- D. Blood pressure and pulse
Explanation: Detailed assessment of a shock patient involves monitoring multiple parameters to guide fluid therapy. ***Urine output*** is a sensitive indicator of **renal perfusion** and overall tissue perfusion, reflecting the adequacy of fluid resuscitation [1]. A target urine output of **0.5-1 mL/kg/hour** is generally used in shock patients to ensure sufficient organ perfusion. *Central Venous Pressure* - **Central Venous Pressure (CVP)** can be a misleading indicator of fluid status, as it reflects right atrial pressure and not necessarily ventricular preload or cardiac output [1]. - While it provides some information, it has limitations as a sole measure for guiding fluid resuscitation due to its poor correlation with **volume responsiveness**, and certain conditions like pulmonary hypertension may raise CVP even in hypovolemia [1]. *Hemoglobin* - **Hemoglobin** levels primarily reflect the oxygen-carrying capacity of the blood and are crucial for diagnosing **anemia** or assessing **blood loss**. - It does not directly indicate the adequacy of fluid volume or tissue perfusion, especially in cases of distributive or cardiogenic shock without significant hemorrhage. *Blood pressure and pulse* - **Blood pressure** and **pulse rate** are important vital signs for assessing the initial response to fluid resuscitation and the presence of shock [1]. - However, they can be maintained within normal limits by compensatory mechanisms even in ongoing hypoperfusion (**compensated shock**), making them less reliable as a sole indicator of adequate fluid replacement [1].
Question 5: In case of PSGN complication commonly seen are all except :
- A. Hypertensive encephalopathy
- B. Bleeding diathesis (Correct Answer)
- C. Hyperkalemia
- D. LVF
Explanation: ***Bleeding diathesis*** - **Post-streptococcal glomerulonephritis (PSGN)** typically does not cause **bleeding diathesis**. Bleeding diathesis is primarily associated with **liver disease**, **bone marrow suppression**, or certain genetic disorders, not directly with PSGN. - While severe kidney failure can indirectly affect coagulation, it's not a common or direct complication leading to **bleeding diathesis** in PSGN. *Hypertensive encephalopathy* - PSGN often leads to **fluid overload** and **renin-angiotensin system activation**, causing severe **hypertension** [1]. - Uncontrolled hypertension can result in **hypertensive encephalopathy**, characterized by headaches, seizures, and altered mental status. *Hyperkalemia* - Renal insufficiency, common in PSGN, impairs the kidneys' ability to excrete **potassium**. - This can lead to **hyperkalemia**, a life-threatening electrolyte imbalance that can cause cardiac arrhythmias. *LVF* - **Fluid overload** and severe **hypertension** in PSGN can overwhelm the heart's pumping capacity [1]. - This can precipitate **left ventricular failure (LVF)**, leading to symptoms like dyspnea and pulmonary edema.
Question 6: What is the best treatment for anemia in patients with Chronic Renal Failure (CRF)?
- A. Oral Iron Therapy
- B. Erythropoietin Stimulating Agents (Correct Answer)
- C. Blood transfusion
- D. Androgenic Steroids
Explanation: ***Erythropoietin Stimulating Agents*** - **Erythropoietin Stimulating Agents (ESAs)** are the cornerstone of anemia treatment in CRF because the primary cause of anemia in these patients is inadequate production of **endogenous erythropoietin** by the damaged kidneys [1]. - ESAs stimulate the bone marrow to produce red blood cells, effectively reversing the anemia and improving symptoms like fatigue and exercise intolerance [1]. *Oral Iron Therapy* - While **iron deficiency** often coexists with **anemia of chronic disease** in CRF patients, oral iron alone is usually insufficient to correct the anemia; it only addresses the iron component. - Many CRF patients have **functional iron deficiency** due to chronic inflammation, which impairs iron utilization, making oral iron less effective even with adequate stores. *Blood transfusion* - **Blood transfusions** provide a rapid increase in hemoglobin but are not the preferred long-term treatment for anemia in CRF due to risks of **iron overload**, **alloreactions**, and potential sensitization, which can complicate future transplantation. - Transfusions are typically reserved for acute, severe anemia or specific circumstances where ESAs are ineffective or contraindicated. *Androgenic Steroids* - **Androgenic steroids** can stimulate erythropoiesis, but their use is limited due to significant side effects such as **hepatotoxicity**, **virilization**, and **cardiac complications**, making them a less favorable option compared to ESAs. - They are considered a secondary or tertiary option, often in patients unresponsive to primary treatments or when other options are exhausted.
Question 7: Assertion: In a patient with chronic kidney disease (CKD) and metabolic acidosis, sodium bicarbonate should be initiated to correct acidosis. Reason: Sodium bicarbonate therapy reduces the progression of kidney disease by decreasing tubular injury and slowing fibrosis.
- A. Assertion is false, but Reason is true
- B. Both Assertion and Reason are true, and Reason is the correct explanation of Assertion
- C. Assertion is true, but Reason is false
- D. Both Assertion and Reason are true, but Reason is NOT the correct explanation of Assertion (Correct Answer)
Explanation: The **Assertion** is true: **KDIGO guidelines** recommend sodium bicarbonate therapy for CKD patients when serum bicarbonate falls below **22 mEq/L** to correct metabolic acidosis [2]. - The **Reason** is also true: studies demonstrate that bicarbonate therapy has **nephroprotective effects**, reducing CKD progression through decreased **tubular injury** and **interstitial fibrosis**. However, this describes a secondary benefit rather than the primary indication for initiating therapy. *Both Assertion and Reason are true, and Reason is the correct explanation of Assertion* - While both statements are medically accurate, the Reason does not explain the primary indication for bicarbonate initiation in CKD patients. - The main purpose is **acid-base correction** and prevention of acidosis complications like **bone disease**, **muscle wasting**, and **cardiovascular effects**, not primarily nephroprotection [1], [2]. *Assertion is false, but Reason is true* - The Assertion is medically correct: sodium bicarbonate is **standard therapy** for metabolic acidosis in CKD according to nephrology guidelines. - CKD patients develop acidosis due to impaired **renal acid excretion** and reduced **bicarbonate regeneration**, making correction clinically necessary [2]. *Assertion is true, but Reason is false* - The Reason is actually supported by **clinical evidence**: randomized controlled trials show bicarbonate therapy slows CKD progression. - Mechanisms include reduced **complement activation**, decreased **endothelin production**, and preservation of **residual kidney function**.
Question 8: The best measure of organ perfusion and the best monitor of adequacy of shock therapy is
- A. urine output (Correct Answer)
- B. restoring blood pressure/pulse vital parameters
- C. central venous pressure
- D. pulmonary wedge pressure
Explanation: ***urine output*** - **Urine output** is a direct and sensitive indicator of **renal blood flow** and, consequently, overall organ perfusion [1]. Adequate urine production (typically >0.5 mL/kg/hr) signifies that the kidneys are being sufficiently perfused, which generally correlates with adequate perfusion of other vital organs. - In the context of shock, improved urine output following therapy indicates effective restoration of **circulating blood volume** and microcirculation, making it an excellent monitor for treatment adequacy. *restoring blood pressure/pulse vital parameters* - While restoring **blood pressure** and **pulse** is a critical goal in shock management, these parameters alone do not always reflect true tissue perfusion [1]. A patient can have normalized blood pressure due to **vasoconstriction** while still experiencing inadequate microcirculatory flow and cellular hypoxia. - These vital signs are systemic indicators, and while essential, they don't provide the same granular insight into **organ-level perfusion** as urine output. *central venous pressure* - **Central venous pressure (CVP)** primarily reflects the **right heart's filling pressure** and overall intravascular volume status [1]. While CVP helps guide fluid resuscitation, it is not a direct measure of organ perfusion. - CVP can be influenced by various factors, including **cardiac function** and **intrathoracic pressure**, and a "normal" CVP does not guarantee adequate perfusion to all organs [1]. *pulmonary wedge pressure* - **Pulmonary wedge pressure (PWP)**, also known as pulmonary artery occlusion pressure, reflects the **left atrial pressure** and serves as an indicator of left ventricular preload [1]. - While PWP is useful in assessing **cardiac function** and guiding fluid management in specific types of shock [1] (e.g., cardiogenic shock), it is not a primary measure of global organ perfusion or a universal monitor for adequacy of shock therapy.
Question 9: Which among the following is an absolute contraindication of Hormone replacement therapy?
- A. Endometriosis
- B. Heart disease
- C. Breast carcinoma (Correct Answer)
- D. Osteoarthritis
Explanation: ### Breast carcinoma - Hormone replacement therapy (HRT) is **contraindicated** in breast carcinoma because many breast cancers are **estrogen-receptor positive**, meaning estrogen can stimulate their growth [1]. - Using HRT in patients with a history of breast cancer significantly increases the risk of **recurrence** or **progression** of the disease [1]. *Endometriosis* - Endometriosis is not an **absolute contraindication**; HRT can sometimes be used in women with a history of endometriosis, especially if a hysterectomy and bilateral oophorectomy have been performed. - However, unopposed estrogen therapy might **exacerbate** remaining endometrial implants, so a combined estrogen-progestin regimen is typically preferred [1]. *Heart disease* - While HRT has been shown to have **risks** in women with established coronary heart disease, it is not an absolute contraindication for all forms of heart disease. - The **Women's Health Initiative study** demonstrated increased cardiovascular events in older women initiating HRT, but current guidelines suggest that timing of initiation is crucial and benefits may outweigh risks for younger postmenopausal women. *Osteoarthritis* - Osteoarthritis is **not a contraindication** to HRT; in fact, some studies suggest that estrogen may have protective effects on cartilage [2]. - HRT is neither a treatment nor a contraindication for osteoarthritis and does not significantly impact its progression or severity [2].
Question 10: In a post-burn patient, which of the following is true?
- A. Hypokalemic alkalosis
- B. Hyperkalemic alkalosis
- C. Hypokalemic acidosis
- D. Hyperkalemic acidosis (Correct Answer)
Explanation: ### Hyperkalemic acidosis - **Massive cell destruction** in severe burns leads to the release of intracellular potassium, causing **hyperkalemia** [1]. - **Metabolic acidosis** often results from tissue hypoperfusion, anaerobic metabolism, and accumulation of lactic acid due to shock and organ dysfunction [1]. *Hypokalemic alkalosis* - This condition is characterized by **low potassium levels** and **elevated pH**, which are not typical early responses to severe burns. - Would more likely be seen with significant **gastrointestinal losses** or certain diuretic use. *Hyperkalemic alkalosis* - While hyperkalemia can occur, the burn injury process typically leads to **acidosis** rather than alkalosis due to tissue damage and hypoperfusion. - This combination is generally contradictory as **severe hyperkalemia** is often accompanied by acidosis. *Hypokalemic acidosis* - **Hypokalemia** is not an immediate finding in severe burns; instead, **hyperkalemia** is expected due to cellular lysis. - Although **acidosis** is common, the potassium derangement described here is inconsistent with acute burn pathophysiology.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free